Delivery Order SPE2DB22D2206-SPE2DB25FJD71
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract valued at $8,896.41. The award was issued on August 5, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a $7,940.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of Tafinlar, a cancer treatment medication, to be delivered to a facility in Conshohocken, Pennsylvania by September 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order from its corporate headquarters using its extensive distribution network to rapidly deliver this critical...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $6,160.65 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 120 capsules of the cancer treatment drug Tafinlar. Performance will take place in Conshohocken, Pennsylvania under a schedule contract held by Amerisourcebergen with the Defense Logistics Agency. The delivery order was awarded on July 5, 2023 and has an end date of July 26, 2023. No subcontractors or...
- This is a $35,585.64 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Tafinlar 75 mg capsules, a medication used in the treatment of certain types of cancer. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award, valued at $17,792.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FGR57) with a firm fixed-price, non-set-aside contract type. It covers the delivery of 4,567,996,469 units of the prescription medication Tafinlar 75 mg capsule, with a performance period extending through May 13, 2025. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 120 capsules of the pharmaceutical drug TAFINLAR 75 mg. The $8,139.33 contract has a completion date of February 7, 2024 and was awarded on January 17, 2024. Amerisourcebergen Drug Corp has a history of providing pharmaceutical products and related distribution services to DLA Troop Support Medical under similar contracts...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $110,210.45 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 120 capsules of the cancer treatment drug Tafinlar. Performance will take place in Conshohocken, Pennsylvania under a period of performance from August 16 to September 7, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the United States Armed Forces by procuring...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,321.30 order is for the delivery of TAFINLAR 50 MG CAPSULES 120S, a pharmaceutical product, to support DLA Troop Support Medical programs and facilities. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to supply pharmaceuticals,...
- This federal contract award, valued at $8,896.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAFINLAR 75 MG CAPSULE 120S, a pharmaceutical product, and has an ultimate completion date of March 13, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 120 capsules of the prescription drug TAFINLAR 75 mg. The contract has a potential value of $8,139.33 and a performance period through March 28, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp serves as the prime contractor, providing...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD71Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,836.26 to AmerisourceBergen Drug Corp for the supply of Tafinlar 50 mg capsules (120 count) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Tafinlar, a cancer treatment medication, represents a routine pharmaceutical procurement supporting the company's established role as a primary vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 7/30/25 |